Literature DB >> 3520307

Tissue culture studies of muscle disorders: Part 2. Biochemical studies, nerve-muscle culture, metabolic myopathies, and animal models.

J A Witkowski.   

Abstract

This review continues with studies of protein, lipid, and purine metabolism of Duchenne muscular dystrophy (DMD) cells in vitro and of muscle cells in combined culture with nerve cells. In vitro studies of human metabolic myopathies are tabulated. Results using the hamster, chicken, and mouse (dy25, dy, mdg, and mdx) myopathies are discussed. Interesting findings include suggestions of altered collagen synthesis by DMD cells. Analysis of cell proteins by two-dimensional gel electrophoresis and the use of combined nerve-muscle cultures remain important areas of development. It is disappointing that so few attempts have been made to repeat significant findings in this field, and when a number of laboratories have examined the same phenomenon, the results are often contradictory. It remains to be shown how these various abnormalities found in cells in vitro are related to each other and to those pathologic features of diseased muscle observed in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3520307     DOI: 10.1002/mus.880090402

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Muscle cell cultures in Menkes' disease: copper accumulation in myotubes.

Authors:  G J van den Berg; J J Kroon; F A Wijburg; K M Sinjorgo; N H Herzberg; P A Bolhuis
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Glycosphingolipids during skeletal muscle cell differentiation: comparison of normal and fusion-defective myoblasts.

Authors:  L D Cambron; K C Leskawa
Journal:  Mol Cell Biochem       Date:  1994-01-26       Impact factor: 3.396

3.  Analyses of the differentiation potential of satellite cells from myoD-/-, mdx, and PMP22 C22 mice.

Authors:  Marion M Schuierer; Christopher J Mann; Heidi Bildsoe; Clare Huxley; Simon M Hughes
Journal:  BMC Musculoskelet Disord       Date:  2005-03-11       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.